Hc. Koh et al., Modification of cardiovascular response of adenosine A(2) receptor agonistby adenylate cyclase in the spinal cord of rats, NEUROSCI L, 293(1), 2000, pp. 45-48
This study was performed to investigate the influence of spinal adenosine A
(2) receptors on the central regulation of blood pressure (BP) and heart ra
te (HR), and to define whether its mechanism is mediated by adenylate cycla
se or guanylate cyclase. Intrathecal (i.t.) administration of drugs at the
thoracic level were performed in anesthetized, artificially ventilated ma l
e Sprague-Dawley rats. Injection (i.t.) of adenosine A(2) receptor agonist,
5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA; 1, 2 and 3 nmol) produced a
dose dependent decrease of BP and HR. Pretreatment with adenylate cyclase
inhibitor, MDL-12,330, attenuated the depressor and bradycardiac effects of
CPCA (2 nmol), but not with guanylate cyclase inhibitor, LY-83,583. These
results suggest that adenosine A(2) receptor in the spinal cord plays an in
hibitory role in the central cardiovascular regulation and that the depress
or and bradycardiac actions are mediated by adenylate cyclase. (C) 2000 Els
evier Science Ireland Ltd. All rights reserved.